Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
J Vasc Interv Radiol ; 6(6): 917-21, 1995.
Article in English | MEDLINE | ID: mdl-8850669

ABSTRACT

PURPOSE: To establish a safe and effective method for occluding a transjugular intrahepatic portosystemic shunt (TIPS) in patients who develop uncontrollable, disabling encephalopathy. PATIENTS AND METHODS: The study population consisted of five patients who developed refractory encephalopathy following TIPS. The indication for TIPS was bleeding in four patients and ascites in one. Wallstents that were 10 mm in diameter and 68 mm long were used to bridge the hepatic parenchyma in all patients. The onset of encephalopathy from the time of the TIPS procedure ranged from 24 hours to 210 days. Because encephalopathy was not responsive to conventional medical management, shunt thrombosis was induced by means of temporary inflation of an 11.5-mm-diameter latex occlusion balloon within the midportion of the stent. RESULTS: All shunts were successfully thrombosed when the balloon was inflated for 12 hours or more. Encephalopathy resolved in four patients and improved in the remaining patient. One patient experienced recurrent bleeding within 24 hours of the TIPS occlusion that was controlled medically. CONCLUSION: Temporary occlusion of a TIPS with latex balloons successfully induces shunt thrombosis and improves encephalopathy. However, the patient is again exposed to risks related to complications of portal hypertension.


Subject(s)
Catheterization , Hepatic Encephalopathy/therapy , Portasystemic Shunt, Surgical/adverse effects , Adult , Ascites/surgery , Catheterization/instrumentation , Embolization, Therapeutic/instrumentation , Esophageal and Gastric Varices/surgery , Female , Follow-Up Studies , Gastrointestinal Hemorrhage/surgery , Hepatic Encephalopathy/etiology , Humans , Hypertension, Portal/surgery , Latex , Male , Middle Aged , Portasystemic Shunt, Surgical/instrumentation , Recurrence , Safety , Stents , Thrombosis/pathology , Time Factors
5.
AJR Am J Roentgenol ; 153(1): 167-71, 1989 Jul.
Article in English | MEDLINE | ID: mdl-2786670

ABSTRACT

Thrombolytic recanalization of arterial bypass grafts has been pursued aggressively in the peripheral circulation but not in the coronary circulation. In an attempt to apply peripheral transcatheter thrombolytic techniques to the coronary circulation, nine patients with 10 occluded saphenous aortocoronary bypass grafts underwent recanalization procedures using a short-duration, high-dose urokinase infusion. Urokinase was infused at the occluded graft orifice at a rate of 600 units/min. The average infusion time was 1 hr, 26 min. The average urokinase dose was 435,000 units. Graft recanalization was achieved in eight (80%) of 10 grafts, although only six (60%) of 10 grafts were widely patent at the end of the procedure. All successfully recanalized grafts required balloon angioplasty of underlying stenoses. No complications, specifically myocardial infarction or cerebrovascular accident, were encountered. We have shown that occluded aortocoronary bypass grafts can be recanalized successfully by using a short-duration, high-dose urokinase infusion. It appears that, with attention given to angiographic techniques that minimize clot manipulation, recanalization can be accomplished safely in a majority of cases.


Subject(s)
Coronary Artery Bypass , Graft Occlusion, Vascular/therapy , Urokinase-Type Plasminogen Activator/administration & dosage , Adult , Aged , Drug Administration Schedule , Female , Humans , Infusions, Intra-Arterial/adverse effects , Male , Mediastinitis/etiology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...